Dabigatran etexilate Recruiting Phase 3 Trials for Pulmonary Embolism (PE) / Venous Thromboembolism (VTE) / Deep Vein Thrombosis (DVT) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03240120A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
NCT01895777Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)